Literature DB >> 15650873

Effect of complex formation between Zn2+ ions and the anticancer drug mithramycin upon enzymatic activity of zinc(II)-dependent alcohol dehydrogenase.

Suman Das1, Pukhrambam Grihanjali Devi, Sudipta Pal, Dipak Dasgupta.   

Abstract

Mithramycin (MTR), a member of the aureolic group of anticancer antibiotics, is a drug that supposedly acts via the inhibition of transcription. It binds to bivalent cations such as Mg(2+) and Zn(2+). In this paper, we report the association of MTR with Zn(2+), a biologically important bivalent cation whose coordination property leads to its important role as a cofactor in different enzymes and nucleosomal DNA-binding proteins. First, we have characterized the complex formation between MTR and Zn(2+) using spectroscopic methods. In the second part, we have examined the effect of the association of Zn(2+) with MTR on the enzymatic activity of a typical zinc(II)-dependent alcohol dehydrogenase (ADH) from yeast. Our data show that MTR forms a single complex with Zn(2+) in a mole ratio of 2:1 in terms of MTR:Zn(2+). We also observe a negative effect for the preincubation of ADH with MTR upon the enzymatic activity. These results indicate that MTR induced structural changes in the enzyme as a sequel to its complex formation with Zn(2+) present in the enzyme, thereby leading to a loss of enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15650873     DOI: 10.1007/s00775-004-0607-3

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  23 in total

Review 1.  Function and mechanism of zinc metalloenzymes.

Authors:  K A McCall; C Huang; C A Fierke
Journal:  J Nutr       Date:  2000-05       Impact factor: 4.798

2.  Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis.

Authors:  C E Outten; T V O'Halloran
Journal:  Science       Date:  2001-06-07       Impact factor: 47.728

3.  Differential interactions of the Mg2+ complexes of chromomycin A3 and mithramycin with poly(dG-dC) x poly(dC-dG) and poly(dG) x poly(dC).

Authors:  S Majee; R Sen; S Guha; D Bhattacharyya; D Dasgupta
Journal:  Biochemistry       Date:  1997-02-25       Impact factor: 3.162

4.  Nucleic acid binding drugs. Some conformational properties of the anti-cancer drug daunomycin and several of its derivatives: implications for DNA-binding.

Authors:  S Neidle; G L Taylor
Journal:  FEBS Lett       Date:  1979-11-15       Impact factor: 4.124

5.  Role of magnesium ion in the interaction between chromomycin A3 and DNA: binding of chromomycin A3-Mg2+ complexes with DNA.

Authors:  P Aich; R Sen; D Dasgupta
Journal:  Biochemistry       Date:  1992-03-24       Impact factor: 3.162

6.  Solution structure of the mithramycin dimer-DNA complex.

Authors:  M Sastry; D J Patel
Journal:  Biochemistry       Date:  1993-07-06       Impact factor: 3.162

7.  Role of magnesium ion in mithramycin-DNA interaction: binding of mithramycin-Mg2+ complexes with DNA.

Authors:  P Aich; D Dasgupta
Journal:  Biochemistry       Date:  1995-01-31       Impact factor: 3.162

8.  Identification of genes responsive to intracellular zinc depletion in the human colon adenocarcinoma cell line HT-29.

Authors:  Birgit Kindermann; Frank Döring; Michael Pfaffl; Hannelore Daniel
Journal:  J Nutr       Date:  2004-01       Impact factor: 4.798

9.  Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters.

Authors:  R C Snyder; R Ray; S Blume; D M Miller
Journal:  Biochemistry       Date:  1991-04-30       Impact factor: 3.162

Review 10.  Zinc enzymes.

Authors:  J E Coleman
Journal:  Curr Opin Chem Biol       Date:  1998-04       Impact factor: 8.822

View more
  1 in total

1.  Inhibition of a Zn(II)-containing enzyme, alcohol dehydrogenase, by anticancer antibiotics, mithramycin and chromomycin A3.

Authors:  Pukhrambam Grihanjali Devi; Prabir Kumar Chakraborty; Dipak Dasgupta
Journal:  J Biol Inorg Chem       Date:  2008-11-26       Impact factor: 3.358

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.